Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ANIX

ANIX News

Newswire

08:16

Anixa Biosciences Receives Approval for Non-Proprietary Name "Liraltagene Autoleucel" for CAR-T Therapy.

11:49

Anixa Biosciences: Market Optimism Difficult to Justify Ahead of Phase 1 Readout.

09:07

Anixa Biosciences Secures U.S. Patent for Breast Cancer Vaccine Technology, Extending IP Protection into 2040s

10:34

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on November 11, 2025

10:33

Anixa Biosciences to participate in Water Tower Research Fireside Chat Series.

View More

About ANIX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More